EXPERIENCES

COVID-19 Experience

NO. YEAR PHASE STUDY TYPE INDICATION
1 2022 Pilot study Local COVID-19 치료제
2 2022 I/IIa Local COVID-19 Vaccine
3 2022 III Local COVID-19 치료제
4 2022 III Global COVID-19 치료제
5 2021 III Local COVID-19 치료제
6 2021 Consulting Local COVID-19 치료제
7 2021 II Local COVID-19 치료제
8 2021 Consulting Local COVID-19 치료제
9 2021 II Local COVID-19 치료제
10 2021 II/III Local COVID-19 치료제
11 2021 III Global COVID-19 Vaccine
12 2021 Consulting Global COVID-19 Vaccine
13 2021 I/IIa Local COVID-19 Vaccine
14 2021 II/III Global COVID-19 치료제
15 2021 II Local COVID-19 치료제
16 2021 I/II Local COVID-19 치료제
17 2021 II Local COVID-19 치료제
18 2021 III Local COVID-19 치료제
19 2021 I/IIa Local COVID-19 Vaccine
20 2021 II Local COVID-19 치료제
21 2020 I/II Local COVID-19 Vaccine
22 2020 I Local COVID-19 치료제
23 2020 III Global COVID-19 Vaccine
24 2020 II Local COVID-19 치료제
25 2020 II Global COVID-19 치료제
26 2020 II Local COVID-19 치료제
27 2020 II Local COVID-19 치료제
28 2020 II Local COVID-19 치료제
29 2020 I/IIa Local COVID-19 Vaccine
30 2020 I/IIa Local COVID-19 Vaccine
31 2020 Medical Device Local COVID-19 진단키트
32 2020 I/IIa Local COVID-19 치료제
[As of 2022.06.30]
치료제 백신 진단키트 2520151050

* LSK Global PS 는 COVID-19 극복을 위해 치료제 개발 22건(Global 3, Local 19), 백신 개발 9건(Global 3, Local 6)과 진단키트 개발 1건의 임상시험을 완료 및 진행하고 있습니다. (2022년 06월 30일 기준)